KNTE
Kinnate Biopharma Inc.
Orbimed Advisors LLC bought $15.0M of Kinnate Biopharma Inc.
Director and 10% owner
Bought$15,000,000
$20.00Price
750,000Shares
−250%Stake
What KNTE did for a copier
Prices for KNTE after this filing aren't in yet.
Orbimed Advisors LLC's record
35 other buys with 3 months of prices since 2016: on average −12.5% against the S&P 500, and 12 of 35 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Dec 2. Filed Fri, Dec 4, 6:11 PM ET, after the close. Not investment advice.